Emmanuel Bachy

53PUBLICATIONS
388CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Sep 30, 2026
A phase 1, first-in-human study of safimaltib, a MALT1 inhibitor, in B-lymphocytic malignancies.

|Aug 21, 2026
Response kinetics following CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry.

|Mar 10, 2026
Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progression.

Linus Wahnschaffe, Dennis Jungherz, Tony A Müller

|Jan 09, 2026
Health-related quality of life after second-line axi-cel in transplant-ineligible patients with large B-cell lymphoma.

Emilie Charton, Amélie Anota, Emmanuel Bachy

|Dec 05, 2025
Early time to relapse as a survival prognosticator in nodal mature T-cell lymphomas: results from the PETAL consortium.

Mark N Sorial, Luis E Malpica Castillo, Carlos Chiattone

|Dec 02, 2025
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.

Matthew J Maurer, Vit K Prochazka, Tarec Christoffer El-Galaly

Pageof 9

Frequent Collaborators

18 joint publications

Franck Morschhauser

18 joint publications

Roch Houot

14 joint publications

Guillaume Cartron

12 joint publications

Francois-Xavier Gros